open access

Vol 68, No 12 (2010)
Letter to the editor
Published online: 2010-12-20
Submitted: 2012-12-28
Get Citation

The use of a novel type of distal protection system (FiberNet®) in the percutaneous management of saphenous vein graft disease

Piotr Pieniążek, Karolina Dzierwa, Piotr Musiałek, Marta Hlawaty, Łukasz Tekieli, Piotr Paluszek, Bartosz Laskowicz, Krzysztof Żmudka, Piotr Podolec
Kardiol Pol 2010;68(12):1423-1425.

open access

Vol 68, No 12 (2010)
Letter to the editor
Published online: 2010-12-20
Submitted: 2012-12-28

Abstract

Percutaneous intervention in saphenous vein grafts is associated with a high risk of distal embolisation by plaque material, ‘no flow’ phenomenon and clinical complications such as myocardial infarction or death. According to randomised trial evidence, intervention in a degenerated vein graft should be performed using an embolic protection device (EPD), since this strategy significantly reduces periprocedural and 30 day adverse event rate. FiberNet® is a novel distal protection system with unique characteristics of a low crossing profile (0.031’’ for vessel size 3.5-5 mm), ‘cotton wool’-like three dimensional design and a small pore size (40 μm). The FiberNet® does not require a separate delivery sheath and self-achieves its optimal apposition to the vessel wall; the EPD system also contains a dedicated aspiration catheter. We present the use of FiberNet® in a 77 year-old patient who had undergone coronary artery bypass grafting 20 years ago and currently presented with CCS class III angina due to a significant stenosis of the saphenous vein graft to the marginal branch. The procedure involved the use of a novel mesh-covered stent (MGuard®) designed to ‘trap’ the plaque material between the stent and the vessel wall. It was technically successful and clinically uncomplicated, and the patient remains well six months later.
Kardiol Pol 2010; 68, 12: 1423-1425

Abstract

Percutaneous intervention in saphenous vein grafts is associated with a high risk of distal embolisation by plaque material, ‘no flow’ phenomenon and clinical complications such as myocardial infarction or death. According to randomised trial evidence, intervention in a degenerated vein graft should be performed using an embolic protection device (EPD), since this strategy significantly reduces periprocedural and 30 day adverse event rate. FiberNet® is a novel distal protection system with unique characteristics of a low crossing profile (0.031’’ for vessel size 3.5-5 mm), ‘cotton wool’-like three dimensional design and a small pore size (40 μm). The FiberNet® does not require a separate delivery sheath and self-achieves its optimal apposition to the vessel wall; the EPD system also contains a dedicated aspiration catheter. We present the use of FiberNet® in a 77 year-old patient who had undergone coronary artery bypass grafting 20 years ago and currently presented with CCS class III angina due to a significant stenosis of the saphenous vein graft to the marginal branch. The procedure involved the use of a novel mesh-covered stent (MGuard®) designed to ‘trap’ the plaque material between the stent and the vessel wall. It was technically successful and clinically uncomplicated, and the patient remains well six months later.
Kardiol Pol 2010; 68, 12: 1423-1425
Get Citation

Keywords

saphenous vein graft disease; embolic protection devices; mesh-covered stent

About this article
Title

The use of a novel type of distal protection system (FiberNet®) in the percutaneous management of saphenous vein graft disease

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 68, No 12 (2010)

Pages

1423-1425

Published online

2010-12-20

Bibliographic record

Kardiol Pol 2010;68(12):1423-1425.

Keywords

saphenous vein graft disease
embolic protection devices
mesh-covered stent

Authors

Piotr Pieniążek
Karolina Dzierwa
Piotr Musiałek
Marta Hlawaty
Łukasz Tekieli
Piotr Paluszek
Bartosz Laskowicz
Krzysztof Żmudka
Piotr Podolec

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl